# Apatinib in patients with extensive-stage small-cell lung cancer after second-line or third-line chemotherapy: a phase II, single-arm, multicentre, prospective study

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/apatinib-in-patients-with-extensive-stage-small-cell-lung-cancer-after-second/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Yanjun Xu,Zhiyu Huang,Hongyang Lu,Xinming Yu,Yuping Li,Wenfeng Li,Jun Chen,Ming Chen,Lei Gong,Kaiyan Chen,Jin Qin,Xiaoling Xu,Ying Jin,Jun Zhao,Xun Shi,Na Han,Fajun Xie,Peng Zhang,Weizhen Xu,Yun Fan |
| Citations | 57 |
| DOI | 10.1038/s41416-019-0583-6 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://www.nature.com/articles/s41416-019-0583-6.pdf |
| OpenAlex ID | https://openalex.org/W2973054798 |
| PMID | 31523058 |
| Type | article |
| Year | 2019 |

## Paper authors

- [Hongyang Lu](https://scholariq.org/researchers/hongyang-lu/)

## Paper journal

- [British Journal of Cancer](https://scholariq.org/journals/british-journal-of-cancer/)

## Paper primary topic

- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)

## Paper topics

- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.